Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20312-36-1

Post Buying Request

20312-36-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20312-36-1 Usage

Chemical Properties

white to light yellow crystal powde

Uses

L-(-)-3-Phenyllactic Acid is used in the synthetic preparation of peptidomimetics as neuropeptide S receptor agonists as well as many other useful compounds.

General Description

L-(-)-3-Phenyllactic acid has been used in the development of degradable self-assembling depsipeptide nanofibers.

Purification Methods

Crystallise the acid from water, MeOH, EtOH or *benzene. [Beilstein 10 IV 653.]

Check Digit Verification of cas no

The CAS Registry Mumber 20312-36-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,3,1 and 2 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 20312-36:
(7*2)+(6*0)+(5*3)+(4*1)+(3*2)+(2*3)+(1*6)=51
51 % 10 = 1
So 20312-36-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8,10H,6H2,(H,11,12)/p-1/t8-/m0/s1

20312-36-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (P1168)  L-(-)-3-Phenyllactic Acid  >98.0%(HPLC)(T)

  • 20312-36-1

  • 1g

  • 350.00CNY

  • Detail
  • TCI America

  • (P1168)  L-(-)-3-Phenyllactic Acid  >98.0%(HPLC)(T)

  • 20312-36-1

  • 5g

  • 990.00CNY

  • Detail
  • Alfa Aesar

  • (A18203)  L-(-)-3-Phenyllactic acid, 98%   

  • 20312-36-1

  • 1g

  • 216.0CNY

  • Detail
  • Alfa Aesar

  • (A18203)  L-(-)-3-Phenyllactic acid, 98%   

  • 20312-36-1

  • 5g

  • 832.0CNY

  • Detail
  • Alfa Aesar

  • (A18203)  L-(-)-3-Phenyllactic acid, 98%   

  • 20312-36-1

  • 25g

  • 3533.0CNY

  • Detail
  • Aldrich

  • (113069)  L-(−)-3-Phenyllacticacid  98%

  • 20312-36-1

  • 113069-1G

  • 327.60CNY

  • Detail
  • Aldrich

  • (113069)  L-(−)-3-Phenyllacticacid  98%

  • 20312-36-1

  • 113069-5G

  • 1,285.83CNY

  • Detail

20312-36-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-3-phenyllactic acid

1.2 Other means of identification

Product number -
Other names (S)-2-Hydroxy-3-phenylpropionic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20312-36-1 SDS

20312-36-1Relevant articles and documents

Novel camphane-based anti-tuberculosis agents with nanomolar activity

Stavrakov, Georgi,Valcheva, Violeta,Philipova, Irena,Doytchinova, Irini

, p. 372 - 379 (2013)

A series of new amidoalcohols and amidodiols were designed on the base of the camphor scaffold and evaluated for their in vitro activity against Mycobacterium tuberculosis H37Rv and MDR strain 43. Some of the new compounds show 25 times higher activity than the classical anti-TB drug ethambutol. Small structural changes in the side chain shift the activity from micromolar to nanomolar inhibitory concentrations. Quantitative structure-activity relationship (QSAR) model is derived to guide the further lead optimization. Two hydrogen bond donors and up to three rings in the molecules are optimal for nanomolar activity. The camphane-based amides present novel promising scaffolds for antimycobacterial agents.

Enantioselective biosynthesis of L-phenyllactic acid by whole cells of recombinant Escherichia coli

Zhu, Yibo,Wang, Ying,Xu, Jiayuzi,Chen, Jiahao,Wang, Limei,Qi, Bin

, (2017)

Background: L-Phenyllactic acid (L-PLA)—a valuable building block in the pharmaceutical and chemical industry—has recently emerged as an important monomer in the composition of the novel degradable biocompatible material of polyphenyllactic acid. However, both normally chemically synthesized and naturally occurring phenyllactic acid are racemic, and the product yields of reported L-PLA synthesis processes remain unsatisfactory. Methods: We developed a novel recombinant Escherichia coli strain, co-expressing L-lactate dehydrogenase (L-LDH) from Lactobacillus plantarum subsp. plantarum and glucose dehydrogenase (GDH) from Bacillus megaterium, to construct a recombinant oxidation/reduction cycle for whole-cell biotransformation of phenylpyruvic acid (PPA) into chiral L-PLA in an enantioselective and continuous manner. Results: During fed-batch bioconversion with intermittent PPA feeding, L-PLA yield reached 103.8 mM, with an excellent enantiomeric excess of 99.7%. The productivity of L-PLA was as high as 5.2 mM·h?1 per OD600 (optical density at 600 nm) of whole cells. These results demonstrate the efficient production of L-PLA by the one-pot biotransformation system. Therefore, this stereoselective biocatalytic process might be a promising alternative for L-PLA production.

Trikoveramides A-C, cyclic depsipeptides from the marine cyanobacterium Symploca hydnoides

Goh, Jun Xian,Katermeran, Nursheena Parveen,Phyo, Ma Yadanar,Tan, Lik Tong

, (2021/07/17)

Trikoveramides A – C, members of the kulolide superfamily of cyclic depsipeptides, were isolated from the marine cyanobacterium, Symploca hydnoides, collected from Bintan Island, Indonesia. Their planar structures were elucidated by a combination of NMR spectroscopy and HRMS spectral data. The absolute configurations of the amino acid and phenyllactic acid units were confirmed by Marfey's and chiral HPLC analyses, respectively, while the relative stereochemistry of the 3-hydroxy-2-methyl-7-octynoic acid (Hmoya) unit in trikoveramide A was elucidated by the application of the J-based configuration analysis and NOE correlations. The cytotoxic activity of the trikoveramides were evaluated against MOLT-4 human leukemia cells and gave IC50 values of 9.3 μM, 35.6 μM and 48.8 μM for trikoveramide B, trikoveramide C and trikoveramide A, respectively. In addition, trikoveramides A – C showed weak to moderate inhibition in the quorum sensing inhibitory assay based on the Pseudomonas aeruginosa lasB-gfp and rhlA-gfp bioreporter strains.

Total synthesis and absolute configuration determination of Ktedonoketone, a benzenoid metabolite from Thermophilic bacterium

Dandawate, Monica,Choudhury, Rahul,Rama Krishna, Gamidi,Srinivasa Reddy

supporting information, (2020/10/30)

The successful total synthesis of both enantiomers of ktedonoketone allowed us to decipher an unambiguous assignment of absolute configuration of the natural product. The concise synthesis highlights Wacker oxidation and aldol condensation as key steps. In addition to this, the current synthetic route is suitable to access a library of compounds on the similar skeleton as one can use readily available amino acids and Grignard reagents as variants.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20312-36-1